GLP-1 Drugs May Increase Dehydration Risk During Extreme Heat. Healthline , 24 July 2025, Cava, Edda, Nai Chien Yeat, and Bettina Mittendorfer
: : 50 ( 8 12 )
2 by Irene Conceio F.Zumub Verified Purchase Very good
A high-calorie liquid nutrient component may be helpful since emptying of liquids is spared
Agonists Exendin-4 (subsequently renamed exenatide, the first FDA approved incretin mimetic), Liraglutide (a longacting DPP-4-resistant GLP-1 receptor agonist), CJC-1131 (a GLP-1 analog engineered for covalent coupling to albumin), Albiglutide (originally referred to as albugon, a recombinant human albumin-GLP-1 protein), ZP10 (an exendin-4 derivative), BIM51077 (subsequently renamed taspoglutide), LY315902 (a DPP-4-resistant GLP-1 analog), LY2428757 (a pegylated GLP-1), LY2199265 (Dulaglutide, an Fc immunoglobulin fusion protein), Semaglutide (a synthetic peptide similar to GLP-1), Lixisenatide (a synthetic peptide similar to exandin-4), and Tirzepatide (LY3298176, a dual agonist of GIP and GLP-1 receptors)
